ELOXX PHARMACEUT

ELOX NASDAQ
6.24
+0.06
+0.97%
已收盘, 17:00 08/16 EDT
开盘
6.24
昨收
6.18
最高
6.51
最低
6.02
成交量
3.16万
成交均量(3M)
8.99万
52周最高
18.50
52周最低
5.14
换手率
0.08%
市值
2.49亿
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供ELOXX PHARMACEUT ELOX股票价格,ELOXX PHARMACEUT股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Eloxx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing ribonucleic acid (RNA)-modulating drug candidates, which are designed to be eukaryotic ribosomal selective glycosides (ERSG). It is developing its drug candidates for treating rare and ultra-rare premature stop codon diseases. ELX-02 is its lead investigational drug product candidate. ELX-02 is a small molecule drug candidate designed to restore production of full-length functional proteins. ELX-02 is in the early stages of clinical development for systemic administration for cystic fibrosis and cystinosis. Its preclinical candidate pool consists of a library of novel ERSG drug candidates identified based on read-through potential and cytoplasmic ribosomal selectivity.
展开 >

最近浏览

名称
价格
涨跌幅